Can Belgian doctor Hans Kluge win the race to lead the WHO?
Belgium’s federal government has nominated Belgian doctor Hans Kluge to become the next Director-General of the World Health Organization, placing the current head of WHO Europe in a contest that will culminate in May 2027.
The next Director-General will oversee the WHO as it manages health emergencies, pandemic preparedness and disease-control standards while responding to a severe funding squeeze and political distrust. For Belgium, the nomination is a significant federal diplomatic initiative, although the office would remain independent of the Belgian government.
’s federal government nominated Belgian doctor for the post of Director-General of the on 21 August 2026, making the serving WHO Regional Director for a prospective candidate to succeed Tedros Adhanom Ghebreyesus. Federal Minister of Social Affairs and Public Health submitted the candidacy with the support of the full government, according to Belgian reporting, while the WHO now lists Kluge among four people proposed by member states. No appointment has been made: nominations remain open until 24 September, and the decisive vote is scheduled for May 2027.
Kluge confirmed the move publicly, saying had nominated him and that he was honoured by the confidence placed in him. Euractiv reported that he took special leave from his regional role on 21 August, as required by WHO election procedures. Corinne Capuano, WHO ’s Director of Programme Management, is handling the regional office’s work during his absence. That safeguard matters because Kluge is not merely campaigning from outside the organisation: he has been responsible for its work across a 53-country European region stretching into .
The candidacy turns a Belgian public-health career into a bid for one of the most politically exposed jobs in international health. Born in Roeselare, Kluge qualified in medicine, surgery and obstetrics at KU Leuven in 1994 and completed tropical-medicine training at Antwerp’s Institute of Tropical Medicine in 1995, according to his official WHO biography. He began as a family doctor before joining Médecins Sans Frontières , working on health emergencies and tuberculosis programmes in Liberia, Somalia and prisons in Siberia.
Kluge joined the WHO in 1999 and subsequently worked on tuberculosis, HIV and health systems in Russia, Myanmar and other countries. He moved to the organisation’s European office in 2009 and became Regional Director in February 2020, just as Covid-19 developed into a global emergency. The appointed him to a second five-year regional term in February 2025 after the European region’s member states unanimously renominated him. That record gives ’s candidate an evident argument: he combines field medicine, institutional experience and recent crisis management.
It does not give him a clear path to victory. The WHO’s prospective-candidate register also lists Hanan Mohammed Al-Kuwari, proposed by Qatar; Hanan Balkhy, proposed by Saudi Arabia; and Indonesian Health Minister Budi Gunadi Sadikin, proposed by Indonesia. More nominations can arrive before the September deadline. The Executive Board will assess the field at its 160th session in 2027 and nominate no more than three candidates. The , in which WHO member states participate, will then appoint the next Director-General at its eightieth session in May 2027. The successful candidate’s five-year term begins on 16 August 2027.
This is therefore a diplomatic campaign as much as a professional selection. can propose Kluge, but it cannot elect him. Winning will require support across regional blocs and among governments with sharply different expectations of the WHO. The federal level is responsible for presenting and promoting Belgium’s candidate internationally: Vandenbroucke holds the relevant public-health portfolio, while Vice-Prime Minister and Minister of Foreign Affairs, European Affairs and Development Cooperation Maxime Prévot oversees the diplomatic network that can canvass member states. Belgium’s regions and communities possess extensive domestic health responsibilities, including important prevention and care functions, but they do not individually nominate candidates for this intergovernmental post.
For Prime Minister Bart De Wever’s federal coalition, formed after the June 2024 election and currently governing in the 2024–2029 legislative cycle, Kluge’s candidacy is an exercise in multilateral influence rather than a change to Belgian healthcare policy. A victory would give a Belgian national unusual visibility at the centre of pandemic preparedness, disease surveillance, vaccination standards and health-emergency coordination. It would not place the WHO under Belgian control: the Director-General is accountable to the organisation’s governing bodies and its full membership, not to the nominating state.
Two competing ideas of the next Director-General’s mandate are already visible. The Belgian government’s choice presents long institutional experience and continuity as assets at a moment of instability. Kluge has argued that the WHO must adapt to geopolitical realities while remaining focused on core public-health work, Euractiv reported. His unanimous European renomination in 2024 also allows supporters to point to an established capacity to work across politically divided states.
A contrasting frame comes from governments questioning the WHO’s performance and independence. The United States, in explaining its withdrawal, accused the organisation of failures during Covid-19 and of compromising its independence; the WHO rejected that account and said withdrawal made both the United States and the world less safe. This constituency will expect the next leader to demonstrate tighter priorities, greater accountability and political neutrality rather than simply preserve existing structures. Separately, the Qatari, Saudi and Indonesian nominations ensure the election cannot be reduced to a European succession plan: states outside may favour leadership reflecting their regions’ experience and influence in global health.
The winner will inherit an organisation under acute financial pressure. WHO member states approved a reduced base programme budget of $4.2 billion for 2026–2027, down from an earlier $5.3 billion proposal, while the organisation attributed a major funding gap to the US withdrawal and cuts by other donors. Tedros told member states in November 2025 that realignment would lead to 1,282 separations following the abolition of positions, alongside retirements and other departures. The leadership debate is consequently about choices as concrete as staffing, emergency capacity and which programmes can be protected.
Kluge’s candidacy is credible because he already operates near the summit of the WHO, but its electoral strength cannot yet be measured. The full official field will not be known until nominations close and the WHO publishes the submitted candidacies after the final regional committee meeting in early November. must now persuade governments that a European insider can both defend multilateral health cooperation and reform an organisation confronting distrust, shrinking resources and recurrent emergencies. The next revealing moments will be the final candidate list, the public candidate forums and the Executive Board shortlist in 2027.
Impact
Regional — Kluge’s leave temporarily changes the leadership of WHO Europe, whose 53-country remit includes Belgium and the wider European and Central Asian region. It does not alter the constitutional division of Belgian health powers.
International — The contest concerns the leadership of a global institution whose standards and emergency coordination affect Belgium, the EU and countries across the world. Kluge’s candidacy also temporarily changes leadership arrangements at WHO Europe, which serves 53 countries across Europe and Central Asia. Belgium can support its nominee diplomatically, but the Director-General is selected by WHO member states and must act independently of the Belgian government. The outcome will matter for international pandemic preparedness, disease-control standards and the organisation’s response to financial and political pressure.
What it means for you
Readers do not need to take immediate action, and the nomination does not change Belgian healthcare access, insurance costs or the division of health responsibilities between federal and regional authorities. The first date to watch is 24 September 2026, when WHO nominations close and the full field should become clearer. In 2027, follow the Executive Board’s possible shortlist of up to three candidates. The decisive appointment is expected at the World Health Assembly in May 2027. Until then, Kluge remains a candidate rather than the WHO’s next confirmed leader.
Opposing perspectives
- Belgian federal government and continuity frame
The De Wever federal government’s nomination treats Kluge’s long WHO experience, field background and unanimous European renomination as strengths. This frame presents an experienced institutional operator as capable of steering the organisation through emergencies, financial pressure and geopolitical division.
- United States institutional-scepticism frame
The United States government has accused the WHO of failures during Covid-19 and of compromising its independence, allegations the organisation disputes. Governments sharing this scepticism are likely to judge candidates on reform, accountability, political neutrality and a tighter definition of the WHO’s core functions.
- Non-European representation frame
Qatar, Saudi Arabia and Indonesia have proposed candidates of their own. Their presence gives member states an alternative to European institutional continuity and may strengthen arguments that the WHO’s leadership should reflect the experience and priorities of regions outside Europe.
Who, where and what
Key people, places and terms in this story
Country whose federal government nominated Kluge on 21 August 2026.
Part of the geographic remit of the WHO regional office currently led by Kluge.
Belgian doctor, WHO Europe director and Belgium’s nominee for WHO Director-General.
Named in the article tags; the supplied article text does not specify his role in the nomination.
Government that formally proposed Kluge for the WHO’s top post.
Show the full library (11)
Belgian doctor, WHO Europe director and Belgium’s nominee for WHO Director-General.
Named in the article tags; the supplied article text does not specify his role in the nomination.
Country whose federal government nominated Kluge on 21 August 2026.
Part of the geographic remit of the WHO regional office currently led by Kluge.
Part of the 53-country remit of WHO Europe.
Member-state selection process culminating in the planned May 2027 appointment.
Government that formally proposed Kluge for the WHO’s top post.
United Nations health agency choosing its next Director-General through a member-state process.
WHO regional body led by Kluge since February 2020, covering 53 countries.
WHO governing body that may shortlist up to three candidates in 2027.
WHO decision-making forum due to appoint the next Director-General in May 2027.
Sources & evidence
- View source7sur7Primaryprimary· 7sur7.be· 21 August 2026Retrieved 26 August 2026· 42 days ago· Dated
- View sourceWHO prospective candidates registerofficial· who.int· 24 August 2026Retrieved 26 August 2026· 39 days ago· Dated
- View sourceWHO Director-General election overviewofficial· who.int· 10 August 2026Retrieved 26 August 2026· 53 days ago· Dated
- View sourceWHO election frequently asked questionsofficial· who.int· 1 August 2026Retrieved 26 August 2026· 62 days ago· Dated
Related topics
Related to this story
Live connections from the Belgium Impulse ecosystem — not recommendations.
This briefing was prepared with AI assistance and reviewed by a Belgium Impulse editor before publication. methodology.